Search for: "2-18-33-1 McDowell" Results 1 - 6 of 6
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Mar 2016, 4:00 am by Howard Friedman
, 33 Law & History Review 887-913 (2015). [read post]
19 May 2010, 4:36 pm by Adam Thierer
 The better alternative would be based on (1) a new legislative framework centered on an FTC-like enforcement model of ex post adjudication grounded in antitrust law; (2) increased industry self-regulation, technical collaboration, and alternative dispute resolution mechanisms; and (3) greater reliance on community policing and expert third-party oversight. [read post]
6 Dec 2016, 8:11 am by Clay Hodges
Dabigatran, because of low bioavailability (3-7%) and a single renal route of elimination, was revealed to have a five-fold variability in patients receiving the same dose.[33] One simulation model showed that at the standard therapeutic dose 18% would receive a sub-therapeutic dose and more than 40% would receive a higher dose than needed, increasing bleeding risk.[26] In a previous analysis of rivaroxaban, we raised questions about its suitability for use under the current dosing… [read post]
4 Oct 2007, 10:09 pm
Isaiah 1:6 reads as follows: "From the sole of the foot even unto the head there is no soundness in it; but wounds, and bruises, and putrefying sores: they have not been closed, neither bound up, neither mollified with ointment. [read post]